A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...

A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Startup Shockwave Medical expects that its Lithoplasty balloon catheters will emerge as a pretreatment for ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...

Bay Area device startup Shockwave Medical just raised $40 million to build out its balloon catheters to be used in peripheral, coronary and aortic valve surgeries. It uses the same basic technology ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the company’s ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced the company’s key activities at the annual Transcatheter ...

Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry Receive the the latest news, research, and ...